Cystosure
Private Company
Funding information not available
Overview
Cystosure has developed the CystoSure® Plus, a novel medical device that combines a urinary catheter with a cystoscope port, creating a streamlined system for diagnostic bladder visualization. Founded by practicing physicians, the company addresses a century-old procedural gap by offering a faster, more standardized, and cost-effective alternative to traditional cystoscopy setups. Its value proposition centers on reducing surgical time, lowering infection risk, and enabling comprehensive bladder diagnostics in a single office visit, thereby improving workflow for clinicians and convenience for patients.
Technology Platform
Patented integrated catheter-cystoscope system featuring a urinary catheter with a dedicated scope port and a pancake balloon for standardized bladder placement and visualization.
Opportunities
Risk Factors
Competitive Landscape
Cystosure competes indirectly with traditional cystoscopy systems from major endoscopy companies (e.g., Olympus, Karl Storz) which are multi-component, non-integrated setups. Its direct competition is limited, as it pioneers the integrated catheter-scope niche for female patients, but it faces competition for capital expenditure budgets and procedural mindshare from these established players.